Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 9, 2007

Nanoviricides and Walter Reed Team Up to Fight Dengue Fever

  • NanoViricides signed a CRADA with the Walter Reed Army Institute of Research (WRAIR). The joint R&D effort will focus on creating new treatments for dengue fever using NanoViricides’ virus-killing nanomedicine technology.

    "This collaboration will leverage Walter Reed’s extensive experience in dengue fever research with our unique nanoviricide™ technology platform for creating antiviral medications," says president, Anil Diwan.

    The company’s TheraCour technologies are used to develop nanotechnology-based targeted antiviral therapeutics.  

  • You’re all set! Thank you for subscribing to GEN Highlights.